Haleon PLC Logo

Haleon PLC

HLN | IL

Overview

Corporate Details

ISIN(s):
GB00BMX86B70 (+1 more)
LEI:
549300PSB3WWEODCUP19
Country:
United Kingdom
Address:
BUILDING 5, FIRST FLOOR, THE HEIGHTS, KT13 0NY WEYBRIDGE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Haleon PLC is a global leader in consumer healthcare, operating as a pure-play business dedicated to improving everyday health. Formerly the consumer healthcare division of GSK, the company's portfolio comprises a wide range of category-leading, over-the-counter (OTC) brands. Its core product areas include oral health, pain relief, respiratory health, digestive health, and vitamins, minerals, and supplements. Key brands under its management include Sensodyne, Panadol, Advil, Voltaren, and Centrum. With a global presence, Haleon focuses on delivering science-backed and trusted health products directly to consumers worldwide.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Haleon PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-26 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-21 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-20 14:20
Major Shareholding Notification
Holding(s) in Company
English 38.6 KB
2025-08-19 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.2 KB
2025-08-18 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-15 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-14 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-13 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-12 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-11 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-08 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-07 17:00
Major Shareholding Notification
Holding(s) in Company
English 38.5 KB
2025-08-07 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-06 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-05 10:15
Director's Dealing
Director/PDMR Shareholding
English 37.5 KB

Automate Your Workflow. Get a real-time feed of all Haleon PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Haleon PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Swedish Orphan Biovitrum Logo
Develops innovative therapies for rare diseases in haematology, immunology, and specialty care.
Sweden SOBI
SymBio Pharmaceuticals Limited Logo Japan 4582
Synbiotic SE Logo
A vertically integrated European group for the entire hemp and cannabis value chain.
Germany SBX
Synektik S.A. Logo
Radiopharmaceuticals, medical devices & IT solutions for oncology, cardiology, and neurology.
Poland SNT
Synthaverse S.A. Logo
Develops and sells oncology, hematology, and immunology drugs and vaccines globally.
Poland BML
TAIKO PHARMACEUTICAL CO., LTD. Logo Japan 4574
Takeda Pharmaceutical Company Limited Logo Japan 4502
TAUNS Laboratories, Inc. Logo Japan 197A
Tchaikapharma High Quality Medicines AD Logo
Manufactures affordable generic & complex polypill medicines for socially significant diseases.
Bulgaria THQM
Teva Pharmaceutical Industries Ltd. Logo
A global leader in generic drugs and innovative medicines for CNS and immuno-oncology.
Israel TEVA